Related Experiment Video
Updated: Nov 25, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Contrast-Induced Nephropathy in patients submitted to percutaneous coronary intervention: an integrative review
Matheus Santos Moitinho1, Eduesley Santana Santos2, Adriano Mendes Caixeta1
1Universidade Federal de São Paulo. São Paulo, São Paulo, Brazil.
Insights
Contrast-induced nephropathy (CIN) incidence in percutaneous coronary intervention (PCI) patients ranges from 6-24%. Advanced age, male gender, diabetes, hypertension, and contrast volume are key risk factors for CIN.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Contrast-induced nephropathy (CIN) is a significant complication following percutaneous coronary intervention (PCI).
- Identifying incidence and risk factors for CIN is crucial for patient management.
Purpose of the Study:
- To review scientific evidence on the incidence of CIN in patients undergoing PCI.
- To identify factors associated with CIN development.
- To elucidate preventive measures for CIN.
Main Methods:
- An integrative review of literature.
- Searched databases: VHL, PubMed, VHL Regional Portal, SciELO.
- Included articles published between 2014 and 2019.
Main Results:
- The incidence of CIN ranged from 6% to 24%.
- Key risk factors identified: advanced age, male gender, diabetes mellitus, systemic arterial hypertension, contrast volume, and osmolarity.
- Effective prophylactic agents include intravenous hydration, sodium bicarbonate, ascorbic acid, and statins.
Conclusions:
- This review highlights major risk factors for CIN in PCI patients.
- Identified preventive strategies can guide multidisciplinary healthcare for safe and quality patient care.
Objective:
to demonstrate scientific evidence on incidence and factors associated with contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
Methods:
an integrative review carried out in the VHL, PubMed, VHL Regional Portal and SciELO databases, of articles published between 2014 and 2019.
Results:
the sample consisted of five original articles, two cohorts, two control cases and a clinical trial. The incidence of contrast-induced nephropathy ranged from 6% to 24%. It stands out among patients with advanced age, male gender, diabetes mellitus, systemic arterial hypertension, volume of contrast infused and osmolarity. Intravenous hydration, sodium bicarbonate, ascorbic acid and statin were important prophylactic agents.
Conclusion:
this study envisioned the main risk factors for contrast-induced nephropathy in patients undergoing percutaneous coronary intervention and elucidated preventive measures that guide multidisciplinary health care aiming at a quality and safe care.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome IV: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Coronary Artery Disease V: Interprofessional Care
Acute Kidney Injury I: Introduction
Continuous Renal Replacement Therapy